Obstructive sleep apnea causes repeated narrowing or closure of the upper airway during sleep. It can fragment sleep and reduce oxygen levels even when a person does not remember waking. Sleep apnea commonly overlaps with obesity, difficult-to-control blood pressure and type 2 diabetes, but symptoms and risk factors cannot confirm the diagnosis. Appropriate sleep testing is usually needed.
Possible clues include:
Not everyone with sleep apnea snores, and not everyone who snores has sleep apnea. Other conditions can also cause tiredness or poor sleep. See the existing guides to iron deficiency and fatigue and obesity as a chronic disease.
When the airway closes, oxygen may fall and the brain briefly activates the stress response to reopen it. Repeated episodes can increase sympathetic nervous-system activity and contribute to blood-pressure elevation. Sleep apnea is therefore particularly relevant when hypertension remains above target despite an appropriate treatment plan.
Home blood-pressure readings can help show the pattern, but they do not diagnose sleep apnea. If your clinician has asked you to keep readings, follow the home blood-pressure log guidance and bring the dated values to the consultation.
Sleep apnea and type 2 diabetes share several risk factors, including obesity and age. Fragmented sleep, intermittent low oxygen and stress-hormone activation may worsen insulin resistance and make glucose management more difficult for some people.
That association does not mean sleep apnea is the only reason for a change in glucose. Medicines, nutrition, physical activity, illness, sleep duration, kidney function and other conditions also matter. Diabetes assessment should consider the full clinical picture rather than attributing every result to sleep.
US diabetes standards of care from the American Diabetes Association (2026) include asking about sleep problems and arranging appropriate assessment when symptoms suggest a sleep disorder. Treating sleep apnea may help sleep-related symptoms and blood-pressure management, but it does not replace the person’s diabetes treatment or guarantee a particular glucose result.
For the clinic’s scope, see Diabetes and metabolic health.
Weight reduction can improve obstructive sleep apnea for many people who live with obesity. Canadian obesity guidance (2025) includes selected obesity medicines alongside health-behaviour changes for adults with moderate-to-severe obstructive sleep apnea and a BMI of at least 30 kg/m². The appropriate option depends on the person’s diagnosis, PAP use, other health conditions, treatment goals, contraindications, access and preferences; the size of benefit varies.
Weight loss should not be described as an automatic cure and should not be used to stop positive airway pressure or another prescribed treatment without reassessment. Airway anatomy, sleep position, alcohol or sedative exposure, nasal obstruction and other factors can remain important after weight changes.
Obesity care should focus on health, function and the patient’s priorities—not blame. Read more about the clinic’s obesity medicine service.
A clinician may review:
A questionnaire can estimate risk but cannot confirm or exclude sleep apnea by itself. Home sleep apnea testing is an option for selected adults without complicating conditions whose symptoms suggest a higher likelihood of moderate-to-severe sleep apnea. If a home test is negative, inconclusive or technically inadequate, an attended sleep study, called polysomnography, is needed to complete the diagnostic assessment. A negative home test does not reliably rule sleep apnea out. Significant heart or lung disease and some other conditions can make an attended study the appropriate first test. Your clinician should choose the testing pathway.
Testing and treatment may require a sleep-medicine service or in-person assessment. Virtual care is not appropriate for every presentation.
Treatment depends on severity, symptoms, anatomy, other medical conditions and patient preferences. Options may include:
Positive airway pressure remains important for many people. Medication used for obesity is not a substitute for diagnostic testing or individualized sleep-apnea care.
Call 911 or attend the nearest emergency department for severe breathing difficulty, chest pain, fainting, new neurological symptoms, severe confusion or another medical emergency.
Do not drive if you may fall asleep. Sleepiness while driving or a driving near-miss requires prompt clinical assessment. A website article or routine virtual appointment cannot assess immediate driving risk.
Helpful information may include:
Dr. Shahzad Clinic provides adult referral-based virtual specialist consultations for patients who are physically located in Ontario at the time of care, when virtual assessment is clinically appropriate. A physician or nurse-practitioner referral is required for new consultations. Referring clinicians should use the referral information. The address referrals@drshahzadclinic.com is for referral coordination only; do not send medical records or other personal health information by ordinary email. Ask the clinic for the appropriate secure route.
The clinic does not provide emergency services. It is a non-procedural virtual practice and does not itself perform sleep studies, supply PAP equipment or provide every treatment described above. In-person, sleep-medicine or hospital-based care may be recommended when needed.
Clinical content approved by Dr. Fowad Shahzad on 4 November 2026.
Referring clinicians may submit relevant clinical information through the clinic’s referral pathway.